loading
前日終値:
$11.13
開ける:
$11.09
24時間の取引高:
27,306
Relative Volume:
0.10
時価総額:
$552.76M
収益:
$62.02M
当期純損益:
$-45.65M
株価収益率:
-12.02
EPS:
-0.92
ネットキャッシュフロー:
$-9.60M
1週間 パフォーマンス:
-1.73%
1か月 パフォーマンス:
+4.49%
6か月 パフォーマンス:
+5.59%
1年 パフォーマンス:
+8.28%
1日の値動き範囲:
Value
$11.05
$11.18
1週間の範囲:
Value
$11.05
$11.41
52週間の値動き範囲:
Value
$7.44
$11.88

Theravance Biopharma Inc Stock (TBPH) Company Profile

Name
名前
Theravance Biopharma Inc
Name
セクター
Healthcare (1162)
Name
電話
650-808-6000
Name
住所
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Name
職員
97
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
TBPH's Discussions on Twitter

TBPH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TBPH
Theravance Biopharma Inc
11.05 565.02M 62.02M -45.65M -9.60M -0.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.72 122.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.97 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.26 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.49 31.91B 3.81B -644.79M -669.77M -6.24

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-06 ダウングレード Leerink Partners Outperform → Market Perform
2024-04-12 開始されました BTIG Research Buy
2024-01-08 ダウングレード Evercore ISI Outperform → In-line
2022-05-23 開始されました SVB Leerink Outperform
2021-11-05 アップグレード JP Morgan Underweight → Neutral
2021-09-15 ダウングレード JP Morgan Overweight → Underweight
2021-08-25 ダウングレード Morgan Stanley Overweight → Underweight
2021-08-24 ダウングレード Cowen Outperform → Market Perform
2020-10-14 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-07 開始されました JP Morgan Overweight
2020-06-15 開始されました Morgan Stanley Equal-Weight
2020-05-13 開始されました Cowen Outperform
2020-01-08 繰り返されました H.C. Wainwright Buy
2019-11-06 アップグレード Robert W. Baird Underperform → Neutral
2019-10-29 開始されました H.C. Wainwright Buy
2018-03-29 再開されました Piper Jaffray Overweight
2017-08-17 開始されました Evercore ISI Outperform
2017-06-16 開始されました Cantor Fitzgerald Overweight
2017-05-11 繰り返されました Needham Buy
2016-12-21 開始されました Needham Buy
2016-11-03 開始されました Piper Jaffray Overweight
2016-10-12 ダウングレード Robert W. Baird Neutral → Underperform
2016-08-03 ダウングレード BofA/Merrill Neutral → Underperform
2016-06-20 開始されました Guggenheim Buy
2016-06-20 繰り返されました Leerink Partners Outperform
2016-05-12 開始されました Leerink Partners Outperform
2016-05-05 ダウングレード BofA/Merrill Buy → Neutral
2015-02-03 アップグレード Robert W. Baird Underperform → Neutral
すべてを表示

Theravance Biopharma Inc (TBPH) 最新ニュース

pulisher
02:51 AM

Why Theravance Biopharma Inc. stock attracts strong analyst attentionWealth Accumulation Stock List - Newser

02:51 AM
pulisher
Jul 24, 2025

Is Theravance Biopharma Inc. a good long term investmentRecord-breaking gains - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Theravance Biopharma Inc. stockUnbelievable profit margins - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

Theravance Biopharma Inc. Stock Analysis and ForecastExceptional trading results - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Theravance Biopharma to Participate in an Upcoming Investor Conference - Citizen Tribune

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Theravance Biopharma Inc. stock priceConsistent triple-digit returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Theravance Biopharma Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser

Jul 22, 2025
pulisher
Jul 17, 2025

Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics - The Globe and Mail

Jul 17, 2025
pulisher
Jul 16, 2025

Theravance Biopharma SVP Farnum sells $113,869 in stock By Investing.com - Investing.com Nigeria

Jul 16, 2025
pulisher
Jul 16, 2025

Theravance Biopharma SVP Farnum sells $113,869 in stock - Investing.com

Jul 16, 2025
pulisher
Jul 16, 2025

5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats - The Globe and Mail

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Theravance Biopharma Inc. stock price move sharplyStrategic High Profit Opportunities - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Viatris Gains China Approval for COPD Drug Yupelri, Triggers $7.5M Payment to Theravance BioPharma - Insider Monkey

Jul 15, 2025
pulisher
Jul 15, 2025

Brokerages Set Theravance Biopharma, Inc. (NASDAQ:TBPH) Target Price at $16.60 - Defense World

Jul 15, 2025
pulisher
Jul 14, 2025

Theravance Biopharma SVP Sells 7,000 Shares for $78,000 on July 14, 2025. - AInvest

Jul 14, 2025
pulisher
Jul 13, 2025

Theravance higher as China approves Viatris-partnered COPD therapy - MSN

Jul 13, 2025
pulisher
Jul 12, 2025

Theravance Biopharma (NASDAQ:TBPH) Downgraded to “Hold” Rating by Wall Street Zen - Defense World

Jul 12, 2025
pulisher
Jun 30, 2025

Theravance Biopharma, Inc.(NasdaqGM:TBPH) dropped from Russell 2000 Defensive Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Theravance Biopharma, Inc.(NasdaqGM: TBPH) added to Russell Microcap Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 28, 2025

Theravance Biopharma (NASDAQ:TBPH) Given New $25.00 Price Target at BTIG Research - Defense World

Jun 28, 2025
pulisher
Jun 27, 2025

TBPH Stock Price Target Increased Following Milestone Payment | TBPH Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

JonesTrading Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Maintains Target Price $24 - 富途牛牛

Jun 27, 2025
pulisher
Jun 26, 2025

Theravance Biopharma price target raised to $25 by BTIG on China approval - Investing.com

Jun 26, 2025
pulisher
Jun 25, 2025

Is Theravance Biopharma, Inc. technically bullish or bearish? - MarketsMojo

Jun 25, 2025
pulisher
Jun 18, 2025

Theravance Biopharma (NASDAQ:TBPH) Now Covered by Jones Trading - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

Theravance Biopharma (NASDAQ:TBPH) Stock Rating Upgraded by Jones Trading - Defense World

Jun 18, 2025

Theravance Biopharma Inc (TBPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.29
price down icon 1.74%
$36.50
price up icon 0.00%
$103.56
price down icon 0.03%
$27.38
price down icon 0.69%
$113.86
price down icon 0.68%
biotechnology ONC
$288.37
price down icon 2.39%
大文字化:     |  ボリューム (24 時間):